The hypothesis is tested that the ras gene of Harvey sarcoma virus (Ha-SV) and the proto-ras DNAs from certain tumor cells derive transforming function from specific codons in which they differ from normal proto-ras genes. Molecularly cloned Harvey proviral vectors carrying viral ras, normal rat proto-ras, and recombinant ras genes in which the virus-specific ras codons 12 and 59 were replaced by proto-ras equivalents each transformed aneuploid mouse 3T3 cells after latent periods that ranged from 4 to 10 days. Viruses with or without virus-specific ras codons all transformed diploid rat cells in 3-5 days equally well. However, in the absence of virus replication, mutant codons were beneficial for transforming function. Deletion of non-ras regions of Ha-SV did not affect transforming function. We conclude that specific ras codons are not necessary for transforming function. Comparisons of the ras sequences of Ha-SV, BALB SV, and Rasheed SV with sequences of proto-ras genes from rat and man revealed an upstream proto-ras exon, termed exon -1. The 3' end of this exon is present in all three viruses and in a ras pseudogene of the rat. Since ras genes transform without mutation and since exon -1 is truncated in viral ras genes and all transforming proto-ras DNAs of the Harvey and the Kirsten ras family, we propose that ras genes are activated by truncation of exon -1 either via viral transduction or artificially via cloning and transfection. The proposal implies that untruncated proto-ras genes with point mutations may not be cellular cancer genes.
erythroleukemias in mice and rats and, in culture, transforms diploid cells from many vertebrate species, including man (1) (2) (3) . The viral ras gene is an autonomous and dominant oncogene that initiates and maintains transformation in one step (2) (3) (4) . It encodes a protein of 189 amino acids, termed p21, that is colinear with a p21 coding sequence of cellular proto (p)-ras genes (5, 6) . Therefore, viral ras and cellular ras genes are assumed to be isogenic (5) (6) (7) (8) (9) (10) (11) (12) (13) (14) .
The apparent paradox that the viral protein has obligatory transforming function, whereas the cellular protein does not, was initially explained in terms of a quantitative hypothesis (5, 6) . This hypothesis suggests that the increased level ofp21 in virus-infected cells causes malignant transformation. The observation that synthetic, virus-type p-ras genes, constructed from Ha-SV promoters and p21 coding regions of molecularly cloned normal rat and human p-ras, can transform aneuploid mouse NIH 3T3 cells (6, 7) is in accord with this hypothesis. A competing hypothesis that is currently favored suggests that viral and cellular ras genes owe transforming function to specific ras codons that differ from normal p-ras codons. The basis for this hypothesis is that p21-encoding p-ras DNA species or clones from certain rodent or human tumors have dominant transforming function, when transfected into cells, due to one of at least 50 different mutations in at least five different ras codons, notably codon 12, whereas equivalent normal DNAs do not (8) (9) (10) (11) (12) (13) (14) (15) (16) (17) (18) 42) . The coincidence that the 12th ras codons of Ha-SV (19) , Rasheed (Ra) SV (20) and BALB murine SV (21) each differ from the 12th codon of normal human (8) (9) (10) and rat (22) p-ras and that the 12th ras codon of the related Kirsten (Ki) SV also differs from Ki-p-ras (23) (24) (25) further supported the mutational rasactivation hypothesis. However, the paradox that a normal cellular gene would be activated to a dominant cancer gene by so many different point mutations although mutations typically are silent or inactivating (26) remained unresolved. It is also unclear why normal p-ras would transform under some (6, 7) but not other conditions (8) (9) (10) (11) (12) (13) (14) (15) (16) (17) (18) . RESULTS 
Transforming Function of ras Genes Without Mutant
Codons. A comparison of the nucleotide sequence of Ha-SV (19) with the sequence of normal rat p-ras-1 (ref. 22 ; M. Ruta, personal communication) shows that ras codons 12 (Arg vs. Gly in p-ras), 59 (Thr vs. Ala), and 122 (Cys vs. Ala) are Ha-SV-specific; the comparison also defines the 5' and 3' borders of the ras sequence of Ha-SV at positions 917 and 1832, for a total of 915 nucleotides (numbered as in ref. 19 and Fig. 1 ). The ras sequence is embedded in sequences derived from a 30S defective rat retrovirus (30S DRV) (27, 28) , which in turn is embedded in terminal elements from Moloney leukemia virus (5, 19) (Fig. 1) .
In preliminary experiments, the role of 30S DRV sequences and of noncoding ras regions on transforming function of Ha-SV was tested with deletion mutants prepared from infectious proviral DNAs, cloned in the plasmid pBR322. One ofthese, pA, is colinear with the viral RNA (27) and is flanked by two LTRs (ref. 29 ; P. Tambourin and D. Lowy, personal communication). The 7.8-kb viral insert begins at a HindIII site at position 3495 of the viral genome, spans the complete provirus, and terminates at a BamHI site at position 378 (Fig. 1) . The other, pH-1, is permuted with regard to an EcoRI site at position 2540 (19, 29) . One such deletion mutant, pAASc, lacks a Sac I-resistant region from position 814 to 1044 of Ha-SV that includes most ras sequences 5' of the p21 coding region (construction in legend to Fig. 1 ). Two others lack 1.7 kb of noncoding ras and 30S DRV sequences 3' of the p21 region, between two Pst I sites at positions 1759 and 3436, or 2.5 kb of DRV sequence 3' of ras, between the two HincII sites at positions 2168 and 4795 (Fig. 1 ). They were constructed by digesting the pH-1 clone with Pst I (29) or HincIl. The digested DNAs were directly transfected into 3T3 cells. Each deletion mutant generated foci of transformed 3T3 cells in 4 to 6 days (see below). Indeed, foci generated by the Sac I deletion mutant were better delineated than wild-type-transformed controls. Virus recovered from transfected cells transformed rat primary cells. Thus, the viral ras gene is not dependent on Proc. Natd. Acad 1695 , was exchanged for the p-ras-2 equivalent. The 0.9-kb BamHI-Fsp I ras region of pA was then replaced by the recombinant equivalent from this clone to construct pA1259-1 as described above. To construct pA1259-2 (not shown), the 2.2-kb Bamfl-EcoRI viral ras region from pA12-2 was subcloned in pMLd. A 0.6-kb Pvu ll(1139)-Nhe I (1695)-resistant viral ras fragment was then exchanged for a p-ras-2 equivalent, and the 0.9-kb BamHI-Fsp I ras fragment of this clone was introduced into pA as described above. pA1259-2ASc was constructed as described above except that a BamHI-Fsp I pA1259 ras fiagment was used from which a region between two Sac I sites at positions 814 and 1044 was deleted. The Sac I region was deleted from a viral BamHI-EoRI region cloned in pMLd. pAprasl-X was constructed by replacing a 0.9-kb HindIU(1088)-Xba I(2023)-flanked viral region from within the aboveBamHI-EcoRI subclone with a 2-kb HindIl-Xba Ifagment ofp-ras-1. A 2.8-kb BamHI-Xba I fiagment from this construct was then ligated with a 5.7-kb Spe I-HindIH fragment of pA containing the 3' LTR and a 2.3-kb HindlI-BamHI fragment of pA containing the 5' LTR, to generate pAprasl-X. Preparation of DNA fiagments, subsequent purification by Elutip (Schleicher & Schuell) chromatography, and ligation followed published procedures (31) . (Lower) The nucleotide sequence 5' of the p21 coding sequence of Ha-SV, from position 900 to 1075 (numbered as in ref. 19 ) is compared to ras sequence equivalents of Ra-SV (20) , BALB SV (21), human (h) p-ras (15, 32) , rat p-ras-1, and rat pseudogene p-ras-2 (refs. 5-7, 22; M. Ruta, personal communication; P. Seeburg, K.C. and P.H.D., unpublished data). X-1 and X1 are exons -1 and 1; SA and SD are splice acceptor and donor sites. noncoding ras and 30S DRV sequences for transforming function.
To test the role of Ha-SV-specific ras codons on transforming function, we have constructed recombinant viruses from pA, in which Ha-SV-specific ras codons were replaced by equivalents from normal rat p-ras DNA. In pA12-1 and -2 the 12th ras codon was replaced by the equivalent of normal rat p-ras-1 ( Fig. 1) or the rat pseudogene p-ras-2, both cloned in pBR322 (6, 7) . In two others, pA1259-1 and -2, the 12th and 59th ras codons were replaced by p-ras-2 equivalents (construction in legend to Fig. 1 ). Both ofthese recombinants also contained the p-ras-2-specific codons 34 (Ser) and 53 (Met), instead of the viral and p-ras-1 equivalents which are Pro and Leu (ref. 19 ; M. Ruta, personal communication). pA1259-1 differs from pA1259-2 in that it contains a 5' noncoding ras region from p-ras-2 ( Fig. 1) . To verify exchange of ras codon 12 in these recombinants, we tested for a Mae I-sensitive CTAG sequence at position 1107 that is characteristic of wild-type Ha-SV (19) . Viruses with the p-ras-specific codon 12 (Gly) contain the Mae I-resistant CTGG sequence (22) .
Finally, a recombinant was constructed, pAprasl-X, in which the viral ras gene was entirely replaced by the rat p-ras-1 equivalent. For (Table 1 ). In the absence of helper virus, focus formation was down by a factor of 100 for pA and by a factor of 1000 for pA12, and the latent period was 2-3 weeks (Table 1 ). The transforming efficiency of recombinants with p-ras codons 12 and 59 (pA1259-1 and -2) was lower by a factor of 3-10, and the latent period was slightly longer than those of pA or pA12 (Table 1) . However, the pA1259-2ASc deletion mutant, which lacks the same noncoding ras region 5' of the p21 coding region as the above-described pAASc, transformed 3T3 cells essentially as well as did pA or pA12 ( Fig. 2 . Foci of pAprasl-X-transformed rat cells had either round or fusiform morphology (Fig. 2 C and D (22) and human (9, 15, 32) p-ras with Ha-SV (19), BALB SV (21), Ra-SV (20) , and the rat pseudogene p-ras-2, at position 1035 (Figs. 1 and 3 ). For this matching, an allowance offour human p-ras-specific triplets was made at position 1056. Upstream of position 1035, the three viruses and the pseudogene share various amounts of additional ras sequences with each other (Figs. 1 and 3) . Moreover, positions 1035 of human and rat p-ras-1 are preceded by exactly the same canonical splice acceptors (Fig. 1) . Thus, this comparison suggests position 1035 as the 5' border of human and rat p-ras exon 1 and signals the existence of an upstream p-ras exon from which the common viral and rat pseudogene sequences 5' of position 1035 must have been derived by the same splicing events. The postulated upstream exon must be conserved in rats and mice, since Ha-SV (5) and Ra-SV (20) originated from rats, and BALB SV (4) from a mouse. Indeed, the available sequence data on human p-ras show a sequence that fits the description of an upstream exon 1040 bp 5' of human p-ras exon 1 (15, 32) (Fig. 3) . The 3'-terminal nucleotides of this sequence (upstream of position 1034 in Fig. 1 ) overlap with the 5'-terminal 144 nucleotides of the known sequence of rat p-ras-2 and the 5' 117, 54, and 24 ras nucleotides of Ha-SV, BALB SV, and Ra-SV, respectively (Figs. 1 and 3) . The human homolog differs from rat p-ras-2 and the viral equivalents only in scattered point mutations, in two specific triplets at position 1006 and in another at position 967 (Fig. 1) . Upstream of position 890 (Fig. 1) Proc. Nad. Acad Sci. USA 83 (1986) p21 expected for an exon, the human sequence is followed by a canonical splice donor, shown at position 1035 in Fig. 1 .
We deduce that rat, mouse, and human p-ras share, in addition to the four exons defined previously, at least one conserved exon, which we refer to as p-ras exon -1 (Figs. 1  and 3 ). The existence of such an exon in human p-ras has been considered previously (15) . Since all three viral ras genes contain terminal elements of this exon, they must have been generated by recombination between this exon and the respective progenitor viruses.
DISCUSSION
Is Transforming Activity of ras Genes due to Truncation of p-ras Exon -1? Our data show that specific mutant codons are not essential for transforming function of p21-encoding Ha-ras genes. Further, we demonstrate that p-ras exon -1 is truncated in all ras-containing SVs, as well as in characterized p-ras DNAs with transforming function (see below). Therefore, we propose that ras genes are activated by truncation of p-ras exon -1 or possibly other upstream exons. In the case of the viral ras genes, this truncation was accomplished by selective transduction, and in the case of p-ras DNAs with transforming function, by fragmentation via transfection or molecular cloning.
Here we itemize examples of how the proposal fits our results and those of others. (i) There is an apparent discrepancy between the results that unmutated p21 has transforming function, as reported here for rat and previously for rat and human p-ras (refs. 6 and 7; P. Tambourin and D. Lowy, personal communication), and the results that it does not (8) (9) (10) (11) (12) (13) (14) (15) (16) (17) . We suggest that the negative results reflect the relative inefficiencies of the assay systems used. The replicating retroviral vector system used by us not only allows optimal recovery of transfected DNA but also provides for optimal expression and transmission by virus spread. For instance, omission of the helper-virus DNA upon transfection reduced focus-forming activity of wild-type Ha-SV by a factor of 100 and transformation by Ha-SV without virus-specific codon 12 by a factor of about 1000 (Table 1) . Thus, <1% of cells transfected become stably transformed in the absence of virus replication. Moreover, a visible focus appears 4-6 days after transfection, due to virus spread, compared to 2-3 weeks after transfection without helper virus. It follows that transforming activity of ras in nonreplicating vectors (single provirus per cell) is at least 10 times more dependent on point mutation than in replicating vectors (multiple proviruses per cell). Thus, the more inefficiently ras is expressed, the more it benefits from mutation for transforming activity. The work ofothers is in accord with this conclusion. For example, when linked to a nonretroviral promoter or to a retroviral promoter (LTR), the 6.6-kb BamHI-resistant human p-ras DNA with a mutant codon 12 and its unmutated equivalent each generate colonies of "immortalized" rat primary cells with equal efficiencies. These colonies were selected by drug-resistance genes cotransfected with ras. However, only the colonies generated by the mutated ras linked to the LTR are reported to be morphologically transformed (16) . We propose that all other ras-immortalized cells are transformants with a fusiform morphology like those shown in Fig. 2D . The negative results reported for other clones ofnormal human p-ras DNA could then be negative because no replicating vectors or enhancers were used and because there was no selection for ras-transfected cells by drug resistance (8) (9) (10) (11) 13) . It is unclear, however, why one other study failed to detect transforming function with unmutated but truncated p-ras in a retroviral vector similar to ours (12) .
(ii) It is improbable that reduced transformation efficiency of some mutant viruses reflects back-mutations, because some mutants retain genetically stable markers that affect the phenotype and the kinetics of transformation and because the frequency of mutation in retroviruses [10-_-10-4 per nucleotide per replicative cycle (36) ] is much too low to account for the 30%-to 90%-reduced transforming efficiencies of some mutant viruses (Table 1) . Instead, less efficient transformation may reflect less efficiently transforming p21 proteins. Further, the later after transfection a focus forms, the more its formation is delayed by interference with helper virus. At high multiplicity of infection with biologically cloned virus, this effect was not apparent, probably because it was compensated for by high p21 dosage. The 10-day latency of pAprasl-X containing normal p-ras-1 could reflect a necessity for a second round of virus replication, because RNA transcribed from unintegrated p-ras DNA with introns may not be spliced (Table 1) .
(iii) Truncation of p-ras exon -1 in a human 6.6-kb BamHI-resistant clone ( Fig. 3; refs. [7] [8] [9] [10] or rat p-ras plasmid clones (6, 7, 22) with transforming function is in accord with our proposal. It is uncertain whether additional DNA carried by some X phages with transforming function belongs to the p-ras gene, since these phages were derived from 3T3 cells transformed by human (37) (38) (39) or rat (22) DNA.
(iv) Deletion ofa 0.8-kb Sac I-resistant region that extends from within exon -1 to intron -1 (Fig. 3) unexpectedly inactivates transforming function of the 6.6-kb human p-ras clone (17) . We suggest that an as yet undefined sequence of exon -1 functions as promoter or that intron -1 includes sequences that inhibit translation ofp21 mRNA. The deletion would either eliminate the promoter or preserve the translation-inhibitory sequence by preventing splicing.
(v) Comparison of the sequences of Ki-SV (23) and p-Kiras DNA (24) reveals that Ki-ras may also be activated by truncation, because Ki-SV also contains the 3' end of an upstream exon (24) . Moreover, both genomic and cDNA clones of p-Ki-ras DNA with transforming function lack all or most of this upstream exon (25) . In contrast, the upstream Ki-ras exon is part of normal p-Ki-ras mRNA and also of a p-Ki-ras pseudogene (24, 25) .
(vi) There is only indirect evidence that p-Ha-ras exon -1 is transcribed, such as the existence of the rat p-ras pseudogene, the size of the mRNAs, or analogy with p-Ki-ras mRNA. p-Ha-ras mRNA species of 1.4-2 kb and 5 kb that have been described in human (39, 40) and rodent cells (41) , and polyadenylylation signals have been located about 400 nucleotides downstream of the p21 stop codon in rat (M. Ruta, personal communication) and in human (15, 32) p-ras.
Thus each of these mRNAs contains more than the known 0.6-kb coding and 0.4-kb noncoding ras sequences. The absence of a suitable promoter in the known human (15, 32) or rat p-ras sequences upstream ofthe p21 sequence [ (ii) The hypothesis that ras genes are activated by truncation is based on a complete structural correlation with all known viral ras genes and p-ras DNAs with transforming function. It preempts and reconciles the hypotheses that ras genes are activated by point mutation or elevated expression. These would each describe relative activations of ras genes that owe absolute transforming activity to truncation. According to this view, virus-specific ras codons are the products of selection for optimal transforming function. These codons were either selected from mutant, perhaps tumor, cells or, more likely9 were generated after transduction, when they were subject to the high mutation frequency of retroviruses (36) . Point mutations in protooncogenes may also condition transforming function of other viral oncogenes. For instance, different viral myb (44) , fps (45) , and myc (46) genes each contain different strain-specific, but no common virus-specific, mutations compared to the corresponding protooncogenes. Since it is unlikely that nonspecific mutations convert protooncogenes to autonomous transforming genes, they are not considered essential for the oncogenic properties of these viruses (4, (44) (45) (46) .
(iii) The hypothesis that p-ras genes of certain tumors are dominant cancer genes due to at least 50 different point mutations in 5 different codons (8) (9) (10) (11) (12) (13) (14) (15) (16) (17) (18) 42) needs to be reevaluated because mutations typically inactivate genes or are silent (26) and because the ras mutations are not necessary for transforming activity. Since in tumors p-ras genes with mutant codons are neither overexpressed (8) nor known to be truncated, there is no experimental evidence that they are cancer genes. Conceivably, these mutations do not "activate" the as yet unknown function ofintact p-ras genes.
The observations that some ras mutations originated subsequent to carcinogenesis (47) (48) (49) argue that they are not necessary for transformation, and those that benign skin papillomas with mutated p-ras genes spontaneously revert to normal (50) argue that they are not sufficient. As p-ras mutations are only very rarely associated with spontaneous tumors (4), they could be one of many other permissible mutations resulting from genetic instability of tumor cells (51) .
Complete definition of p-ras genes is necessary to test the truncation hypothesis.
Note Added in Proof: A p-ras cDNA that includes part of exon -1 as defined here has been described and four initiation sites for ras transcription between positions 1000 and 1020 ( Fig. 1) have been deduced (43) . We question these initiation sites because sequences 5' of position 1000 are in the rat pseudogene (Figs. 1 and 3 ) and because the 80 p-ras-derived nucleotides of HaSV upstream of these initiation sites do not function as promoters.
